AMERICAN SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY
LIVE

Serial Number

88460299

Owner

American Society for Transplantation andCellular Therapy

Attorney

Kimberly A. Pendo

First Use Date

Mar 5, 2019

Filing Date

Jun 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

AMERICAN SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY Trademark

Serial Number: 88460299 • Registration: 5963686

AMERICAN SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY is a trademark filed by American Society for Transplantation andCellular Therapy on June 5, 2019. The trademark is classified under Class 41 (Education & Entertainment), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

American Society for Transplantation andCellular Therapy (2 trademarks)

330 North Wabash Avenue, Suite 2000
Chicago, IL 60611

Entity Type: 99

American Society for Transplantation and Cellular Therapy (5 trademarks)

330 North Wabash Avenue, Suite 2000
Chicago, IL 60611

Entity Type: 99

Trademark Details

Filing Date

June 5, 2019

Registration Date

January 14, 2020

First Use Anywhere

March 5, 2019

First Use in Commerce

March 5, 2019

Goods & Services

Printed instructional and educational materials in the field of blood and marrow transplantation and related cellular therapies; publications, namely, journals and newsletters in the field of blood and marrow transplantation and related cellular therapies

Educational services, namely, conducting, organizing and teaching seminars, workshops, educational conferences, educational symposiums, webinars, classes, and training, and providing educational examination services and educational testing services, in the field of blood and marrow transplantation and related cellular therapies; publication of journals and newsletters in the field of blood and marrow transplantation and related cellular therapies

Association services, namely, promoting education, advocacy and research in the field of blood and marrow transplantation and related cellular therapies

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jun 3, 2026 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jun 3, 2026 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 18, 2026 APRE
TEAS SECTION 8 RECEIVED
Jan 7, 2026 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 14, 2025 REM1
REGISTERED-SUPPLEMENTAL REGISTER
Jan 14, 2020 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 10, 2019 PREV
ASSIGNED TO LIE
Dec 3, 2019 ALIE
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Nov 27, 2019 CNTA
EXAMINER'S AMENDMENT ENTERED
Nov 27, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 27, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 27, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 27, 2019 CNEA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Nov 24, 2019 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Nov 24, 2019 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Nov 24, 2019 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Nov 24, 2019 CPEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 27, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 27, 2019 GNRT
NON-FINAL ACTION WRITTEN
Aug 27, 2019 CNRT
ASSIGNED TO EXAMINER
Aug 27, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 19, 2019 NWOS
NEW APPLICATION ENTERED
Jun 8, 2019 NWAP